PRAME and melanoma: Upregulation of preferentially expressed antigen in melanoma (PRAME) has been reported to be a common event in melanomas, and relatively recently, immunohistochemistry for PRAME has been shown to be diagnostically helpful in evaluating various melanocytic lesions [15].